Holdings (as at 2026-08-20)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
Regeneron Pharmaceuticals, Inc. 2.83%
Natera, Inc. 2.56%
Universal Health Services, Inc. (Class B) 2.48%
Boston Scientific Corporation 2.47%
Pfizer Inc. 2.46%
Zimmer Biomet Holdings, Inc. 2.45%
Solventum Corporation 2.45%
Guardant Health, Inc. 2.39%
Tenet Healthcare Corporation 2.32%
Globus Medical, Inc. (Class A) 2.32%
Corcept Therapeutics Inc. 2.22%
Halozyme Therapeutics, Inc. 2.16%
Centene Corporation 2.13%
The Cigna Group 2.12%
Encompass Health Corporation 1.91%
Medtronic Plc 1.88%
ResMed Inc. 1.87%
QIAGEN N.V. 1.83%
Axsome Therapeutics, Inc. 1.81%
Incyte Corporation 1.79%
Medline Inc. (Class A) 1.76%
Arrowhead Pharmaceuticals, Inc. 1.71%
DaVita Inc. 1.68%
Zoetis Inc. 1.66%
Eli Lilly and Company 1.65%
Elevance Health Inc. 1.63%
Doximity, Inc. (Class A) 1.60%
Becton, Dickinson and Company 1.59%
United Therapeutics Corporation 1.53%
Ascendis Pharma A/S 1.52%
Labcorp Holdings Inc. 1.52%
Medpace Holdings, Inc. 1.49%
GE HealthCare Technologies Inc. 1.48%
Quest Diagnostics Incorporated 1.46%
Gilead Sciences, Inc. 1.46%
Bristol-Myers Squibb Company 1.45%
Neurocrine Biosciences, Inc. 1.45%
Revolution Medicines, Inc. 1.45%
Steris Plc 1.43%
Viatris Inc. 1.30%
Biogen Inc. 1.27%
Exelixis, Inc. 1.26%
Veeva Systems Inc. (Class A) 1.12%
IQVIA Holdings Inc. 1.06%
Abbott Laboratories 1.00%
Thermo Fisher Scientific Inc. 1.00%
Ionis Pharmaceuticals, Inc. 0.95%
Agilent Technologies, Inc. 0.94%
Tempus AI, Inc. (Class A) 0.92%
Chemed Corporation 0.91%
BridgeBio Pharma, Inc. 0.89%
Vertex Pharmaceuticals Incorporated 0.87%
Henry Schein, Inc. 0.84%
HCA Healthcare, Inc. 0.83%
AbbVie Inc. 0.83%
Organon & Co. 0.81%
Madrigal Pharmaceuticals, Inc. 0.77%
Align Technology, Inc. 0.75%
DexCom, Inc. 0.53%
Bio-Rad Laboratories, Inc. (Class A) 0.51%
Amgen Inc. 0.48%
Illumina, Inc. 0.48%
BioMarin Pharmaceutical Inc. 0.47%
Merck & Co., Inc. 0.46%
Danaher Corporation 0.45%
Revvity, Inc. 0.45%
The Ensign Group, Inc. 0.45%
Johnson & Johnson 0.42%
The Cooper Companies, Inc. 0.42%
Stryker Corporation 0.41%
IDEXX Laboratories, Inc. 0.41%
Envista Holdings Corporation 0.41%
West Pharmaceutical Services, Inc. 0.39%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.